These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31171490)

  • 1. Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy - A systematic review of the literature using lacosamide as an example.
    Arzimanoglou A; Kalilani L; Anamoo MA; Cooney M; Golembesky A; Taeter C; Bozorg A; Tofighy A; Wheless J
    Eur J Paediatr Neurol; 2019 Jul; 23(4):589-603. PubMed ID: 31171490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
    Sanmartí-Vilaplana F; Díaz-Gómez A
    Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
    Hoy SM
    CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.
    Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P
    J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Kobayashi Y; Honda R; Yamada K; Hojo M; Miura M; Seki E; Ono T; Tohyama J
    Brain Dev; 2023 Sep; 45(8):451-455. PubMed ID: 37308336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures.
    Trinka E; Lattanzi S; Carpenter K; Corradetti T; Nucera B; Rinaldi F; Shankar R; Brigo F
    CNS Drugs; 2021 Aug; 35(8):821-837. PubMed ID: 34232492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide in children with drug-resistant epilepsy.
    Rüegger AD; Freeman JL; Harvey AS
    J Paediatr Child Health; 2019 Feb; 55(2):194-198. PubMed ID: 30051539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials.
    Johnson ME; McClung C; Bozorg AM
    Epilepsia Open; 2021 Jun; 6(2):359-368. PubMed ID: 34033237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy).
    Samarasekera SR; Berkovic SF; Scheffer IE
    J Sleep Res; 2018 Oct; 27(5):e12669. PubMed ID: 29479765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.